Four Groups

Nick Carr takes a wonderfully tangential view on pharmacology and productivity.

I recently commented on the Nature editorial that made a case for “the responsible use of cognitive-enhancing drugs by the healthy.”

The writers of the editorial, a distinguished group of academics, had noted that artificial “cognition enhancement” could boost the performance and productivity of many workers: “From assembly line workers to surgeons, many different kinds of employee may benefit from enhancement and want access to it.”

In a posting today, the law professor Frank Pasquale takes the next logical step, offering a modest proposal for also allowing the use of “cognition-dulling drugs” by the healthy.

It brings a whole new meaning to work-life balance!